Quantinno Capital Management LP Purchases 33,793 Shares of Agilent Technologies, Inc. (NYSE:A)

Quantinno Capital Management LP raised its position in Agilent Technologies, Inc. (NYSE:A) by 48.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 103,004 shares of the medical research company’s stock after purchasing an additional 33,793 shares during the period. Quantinno Capital Management LP’s holdings in Agilent Technologies were worth $13,838,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Mufg Securities Americas Inc. bought a new stake in shares of Agilent Technologies during the 4th quarter worth $570,000. Man Group plc lifted its holdings in shares of Agilent Technologies by 4.2% during the 4th quarter. Man Group plc now owns 311,374 shares of the medical research company’s stock worth $41,830,000 after acquiring an additional 12,581 shares during the last quarter. Nomura Holdings Inc. bought a new stake in shares of Agilent Technologies during the 4th quarter worth $1,272,000. NorthRock Partners LLC lifted its holdings in shares of Agilent Technologies by 151.7% during the 4th quarter. NorthRock Partners LLC now owns 4,394 shares of the medical research company’s stock worth $590,000 after acquiring an additional 2,648 shares during the last quarter. Finally, Meridiem Capital Partners LP purchased a new position in Agilent Technologies in the 4th quarter worth $29,492,000.

Agilent Technologies Stock Down 3.4%

A stock opened at $111.49 on Thursday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $155.35. The stock has a market capitalization of $31.79 billion, a PE ratio of 25.63, a price-to-earnings-growth ratio of 3.25 and a beta of 1.27. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The company has a fifty day moving average of $110.78 and a 200-day moving average of $128.45.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. As a group, analysts expect that Agilent Technologies, Inc. will post 5.54 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were paid a dividend of $0.248 per share. The ex-dividend date was Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.89%. Agilent Technologies’s payout ratio is 22.76%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Barclays decreased their price objective on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. Jefferies Financial Group dropped their price objective on shares of Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a research note on Monday, April 21st. TD Cowen upped their target price on shares of Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research note on Thursday, April 10th. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating for the company in a report on Thursday, April 17th. Finally, Robert W. Baird reduced their target price on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a report on Thursday, February 27th. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $143.00.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now owns 21,786 shares of the company’s stock, valued at $2,657,456.28. The trade was a 8.05% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the sale, the director now owns 35,737 shares of the company’s stock, valued at $4,161,931.02. This trade represents a 4.84% decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.